Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Hypertriglyceridemia

Interventions

DRUG

warfarin

A single 25 mg dose of warfarin

DRUG

omefas

4 x 1 g capsule dose of Epanova®

DRUG

omega-3-acid ethyl esters

4 x 1 g capsule dose of Lovaza®

Trial Locations (1)

Tempe